EastGate Biotech Corp., an emerging pharmaceutical company aimed at utilizing drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules, has announced that its research collaborator, the University of Guelph, Department of Molecular and Cellular Biology received a grant from the National Sciences and Engineering Research Council of Canada (NSERC).
The grant was approved for the development and evaluation of new nano delivery vehicles for natural antimicrobial products with improved efficacy..
Previously the company announced that its research collaboration with the University of Guelph involved measuring the antimicrobial activity of the company's natural antibacterial products, Cleanezze™ and Vclean™. Cleanezze™ is a long acting hand sanitizer that contains 3 different natural antibacterial compounds. Vclean™ is a natural, non-toxic and highly effective concentrate for the elimination of dangerous germs from surfaces of fruits, vegetables, kitchen tools, etc. The results of this study demonstrated the effectiveness of these products.
The research team at the University of Guelph led by Principal Investigator, Dr. Cezar Khursigara will continue to study the antimicrobial activity of our products.
"We are pleased with the grant awarded to our collaborators at the University of Guelph," says Anna Gluskin, EastGate's CEO. "This support will serve to validate the effectiveness of the company's natural antibacterial products and provide the competitive benefits for the demanding marketplace looking to combat increases in microbial outbreaks," continued Ms. Gluskin.